Monthly and Quarterly Financial Information. Envista will deliver or make available to Xxxxxxx a consolidated income statement and balance sheet, or the information required to prepare a consolidated income statement and balance sheet, on a monthly basis for Envista for such period in the same format and manner, with the same detail, and in the same timeframe, as the Envista Business delivered or made available such information to Xxxxxxx prior to the Effective Date (such practices, the “Financial Delivery Practices”). Envista will deliver or make available to Xxxxxxx a consolidated income statement and balance sheet and supplemental data related to cash flows, or the information required to prepare a consolidated income statement and balance sheet and supplemental data 49 related to cash flows, and other necessary disclosures on a quarterly basis in accordance with the Financial Delivery Practices. Envista will be responsible for reviewing its results and data and for informing Xxxxxxx immediately of any post-closing adjustments that come to its attention. Envista must provide final sign-off of its results, using Xxxxxxx’x materiality standards, no later than nine (9) Business Days after the quarterly close period end for the income statement and no later than twelve (12) Business Days after the quarterly close period end for the balance sheet and supplemental data, in each case unless otherwise directed by Xxxxxxx. A certification will be provided by the Chief Executive Officer and Chief Financial Officer of Envista that the quarterly financials and internal controls appropriately represent the financial position and current financial reporting controls of Envista no later than five (5) Business Days prior to Xxxxxxx’x filing of its quarterly financial statements with the Commission.
Monthly and Quarterly Financial Information. Centuri will, and will cause each member of the Centuri Group to, from and after the IPO Effective Date:
Monthly and Quarterly Financial Information. The Company and each of its Subsidiaries and Affiliates will deliver to Pfizer an income statement and balance sheet on a monthly basis for the Company for such period in such format and detail as Pfizer in accordance with Schedule 7.01(c). The Company and each of its Subsidiaries and Affiliates will deliver to Pfizer an income statement and balance sheet and supplemental data related to cash flows and other necessary disclosures on a quarterly basis in accordance with Schedule 7.01(c) in such format and detail as Pfizer may request. The Company will be responsible for reviewing its results and data and for informing Pfizer immediately of any post-closing adjustments that come to its attention. The Company must provide final sign-off of its results, using Pfizer materiality, no later than seven (7) Business Days after the quarterly close period end for the income statement and no later than fourteen (14) Business Days after the quarterly close period end for the balance sheet and supplemental data. A certification will be provided by the Controller and Chief Financial Officer and President of the Company pertaining to the quarter financials and internal controls no later than five (5) Business Days prior to Pfizer’s filing of its quarterly financial statements with the Commission.
Monthly and Quarterly Financial Information. Venator and each of its Subsidiaries and Affiliates will deliver to Huntsman an income statement and balance sheet on a monthly basis for Venator for such period in such format and detail as Huntsman in accordance with Schedule 9.1(c). Venator and each of its Subsidiaries and Affiliates will deliver to Huntsman an income statement and balance sheet and supplemental data related to cash flows and other necessary disclosures on a quarterly basis in accordance with Schedule 9.1(c) in such format and detail as Huntsman may request. Venator will be responsible for reviewing its results and data and for informing Huntsman immediately of any post-closing adjustments that come to its attention. Venator must provide final sign-off of its results, using Huntsman materiality, no later than seven (7) Business Days after the quarterly close period end for the income statement and no later than fourteen (14) Business Days after the quarterly close period end for the balance sheet and supplemental data. A certification will be provided by the Controller and Chief Financial Officer and President of Venator pertaining to the quarter financials and internal controls no later than five (5) Business Days prior to Huntsman’s filing of its quarterly financial statements with the SEC.
Monthly and Quarterly Financial Information. As soon as practicable, and within 10 Business Days after the end of each month in each fiscal year of the Company, the Company shall deliver to each such Principal Stockholder a statement of operations and balance sheet for Evolent Health, Inc. and Evolent Health LLC for such month. As soon as practicable, and within 11 Business Days after the end of each fiscal quarter in each fiscal year of the Company, the Company shall deliver to each such Principal Stockholder a statement of shareholders’ equity for Evolent Health, Inc. and Evolent Health LLC for such quarter.
Monthly and Quarterly Financial Information. As soon as available and in any event within forty-five (45) days after the end of each month during the period from the date hereof through and until March 31, 2001, and thirty (30) days after the end of each month after April 1, 2001, the Company shall deliver (i) the consolidated and consolidating balance sheets of the Company and its Subsidiaries, as at the end of such month and the related consolidated and consolidating statements of income, stockholders' equity and cash flow for such month and for the period from the beginning of the then current fiscal year of the Company to the end of such month (and, with respect to financial statements delivered for months that are also the last month of any fiscal quarter, accompanied by the related consolidated and consolidating statements of income, stockholders' equity and cash flow for such fiscal quarter) and (ii) a schedule of the outstanding Indebtedness for borrowed money of the Company and its Subsidiaries describing in reasonable detail each such debt issue or loan outstanding and the principal amount and amount of accrued and unpaid interest with respect to each such debt issue or loan.
Monthly and Quarterly Financial Information. As soon as available and in any event within thirty (30) days after the end of each month, the Company shall deliver (i) the consolidated and consolidating balance sheets of the Company and its Subsidiaries, as at the end of such month and the related consolidated and consolidating statements of income, stockholders' equity and cash flow for such month and for the period from the beginning of the then current fiscal year of the Company to the end of such month (and, with respect to financial statements delivered for months that are also the last month of any fiscal quarter, accompanied by the related consolidated and consolidating statements of income, stockholders' equity and cash flow for such fiscal quarter) and (ii) a schedule of the outstanding Indebtedness for borrowed money of the Company and its Subsidiaries describing in reasonable detail each such debt issue or loan outstanding and the principal amount and amount of accrued and unpaid interest with respect to each such debt issue or loan. Notwithstanding the foregoing to the contrary, from and after January 1, 2001, the financial information required to be delivered pursuant to this paragraph shall be delivered as soon as available following the end of each fiscal quarter, but in no event later than thirty (30) days after the end of such fiscal quarter. After the consummation of an IPO, as defined in the Certificate (an "IPO") the Company's obligations under this paragraph (a) shall continue until the second anniversary of the date of this Agreement, but the financial information shall be provided to the Company's Board of Directors and observers, not to the Purchasers.
Monthly and Quarterly Financial Information. As soon as available and in any event within twenty-five (25) days after the end of each month (including months that are also the last month of a fiscal quarter). The Company shall deliver the monthly financial report prepared for internal management review, substantially in the form of the report for July, 2000 delivered to Purchasers. As soon as available and in any event within forty-five (45) days after the end of each fiscal quarter (ninety (90) days with respect to fiscal quarters that are also the last fiscal quarter of the fiscal year), the Company shall deliver (i) the consolidated and consolidating balance sheets of the Company and its Subsidiaries, as at the end of such quarter and the related consolidated and consolidating statements of income and consolidated cash flow for such quarter and for the period from the beginning of the then current fiscal year of the Company to the end of such quarter and (ii) a schedule of the outstanding Indebtedness for borrowed money of the Company and its Subsidiaries describing in reasonable detail each such debt issue or loan outstanding and the principal amount and amount of accrued and unpaid interest with respect to each such debt issue or loan.
Monthly and Quarterly Financial Information. The Company and each of its Subsidiaries and Affiliates will deliver to Pfizer an income statement and balance sheet and supplemental data related to cash flows and other necessary disclosures on a quarterly basis in accordance with Schedule 7.01(c) in such format and detail as Pfizer may request. The Company will be responsible for reviewing its results and data and for informing Pfizer immediately of any post-closing adjustments that come to its attention. The Company must provide final sign-off of its results, using Pfizer materiality, no later than seven (7) Business Days after the quarterly close period end for the income statement and no later than fourteen (14) Business Days after the quarterly close period end for the balance sheet and supplemental data. A certification will be provided by the Controller and Chief Financial Officer and President of the Company pertaining to the quarter financials and internal controls no later than five (5) Business Days prior to Pfizer's filing of its quarterly financial statements with the Commission.
Monthly and Quarterly Financial Information. As soon as available and in any event within forty-five (45) days after the end of each month, the Corporation shall deliver (i) the balance sheet of the Corporation, as at the end of such month and the related statements of income, stockholders' equity and cash flow for such month and for the period from the beginning of the then current fiscal year of the Corporation to the end of such month (and, with respect to financial statements delivered for months that are also the last month of any fiscal quarter, accompanied by the related consolidated and consolidating statements of income, stockholders' equity and cash flow for such fiscal quarter) and (ii) a schedule of the material outstanding Indebtedness for borrowed money of the Corporation describing in reasonable detail each such debt issue or loan outstanding and the principal amount and amount of accrued and unpaid interest with respect to each such debt issue or loan. Notwithstanding the foregoing to the contrary, from and after January 1, 2002, the financial information required to be delivered pursuant to this paragraph shall be delivered as soon as available following the end of each fiscal month, but in no event later than thirty (30) days after the end of such fiscal month.
